23.4.3 A risk disclosure statement provided by an Authorised Person to a Retail Client in

accordance with Rule 23.4.1 must include a prominent warning that investing in OTC Leveraged Products involves the risk of losing substantially more than the initial margin posted by the Retail Client, and further state that:

(a)

the risk disclosure statement may not identify or address all risks associated with OTC Leveraged Products;

(b)

the Retail Client is at risk of losing all of their capital outlay and any profits not redeemed;

(c)

the Retail Client is at risk of losing money and accumulating losses rapidly;

(d) margin trading and use of leverage amplifies losses when they occur;